| Website | wilmingtonpharma.com |
| Category | BioTech |
| Phone | 910-509-0097 |
| info@wilmingtonph... | |
| Employees |
| TOTAL | $1.3M |
| FUNDING TOTAL | $1.3M |
| Series B, 10/06 Wilmington Investor Network Emergent Growth Fund | $1.3M |
At Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.
